Since ATP generation through glycolysis is less efficient and therefore requires a higher rate of NAD/NADH redox reactions [9], cancer cells with rapid turnover and high bioenergetics requirements relying on NAD+ may be more sensitive to NAMPT inhibition [5], suggesting its therapeutic potential for cancer treatment. Here, NAMPT is linked to cancer.